Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Reimbursement resources
Return a product
Customer support

Call customer care

1 (888) 272-1001

Bulkamid™ Urethral Bulking System product shot.

Bulkamid™ Urethral Bulking System

Bulkamid is a minimally invasive, long-lasting treatment option to treat bladder leaks caused by stress urinary incontinence (SUI). Bulkamid is a non-particulate homogeneous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide.
Explore product details

Reimbursement

Bulkamid reimbursement guide

Configure or select a product to continue to order

Why choose Bulkamid?

Bulkamid is a unique bulking agent.

Illustration of Bulkamid water drop.

Unique composition

Bulkamid is a non-particulate homogeneous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide.

Bulkamid™ Urethral Bulking System product shot.

Precision delivery system

The Bulkamid delivery system was designed to provide a reproducible, efficient, predictable injection procedure.

Icon of a stethoscope with a checkmark.

Long lasting 

Designed to effectively treat SUI, with clinical support up to 7 years.1

Bulkamid Urethral Bulking Step‑by‑Step Procedure

This animation demonstrates the Bulkamid procedure.

 

In one study, 64% of women chose Bulkamid to treat their SUI over other options.2

Pie chart showing 64% of women chose Bulkamid and 36% chose alternative surgical interventions.

What’s included

Advantage™ Fit Transvaginal Mid-Urethral Sling System product shot.

The kit includes:

  • 2x 1 mL Bulkamid syringes
  • 2x 23G, 12 cm needles
  • 1x Bulkamid rotatable sheath

Additional components include:

  • Bulkamid Cystoscope sterilization container
  • Zero-degree Bulkamid cystoscope with universal connections
  • Universal adapters to fit all light cables
  • Protection sheath for transportation

Studies and data

2025, Urology, Faurie et al.   
Outpatient PAHG injections under local anesthesia: prospective single‑center series.  

2025, Journal of Urogynecology, Lamblin et al. 
Effectiveness and safety of urethral bulking with Bulkamid®: French multicenter cohort.  

2025, New England Journal of Medicine, Itkonen et al.
TS. TVT vs PAHG — 5‑year follow‑up.  

2024, The World Journal of Urology, Uleri et al.   
One‑year outcomes of PAHG injection in women with stress and mixed UI.  

2023, Journal of Urological Surgery, Köseoğlu et al.   
Minimally invasive treatment of female SUI with PAHG: Turkish cohort including mixed UI and prior failed surgery. 

2022, Journal of Urology, Itkonen et al. 
TVT vs PAHG — 3‑year follow‑up from RCT.  

2022, BJU International, Hoe et al.
Long‑term outcomes of polyacrylamide hydrogel treatment in women with SUI.  

2021, Neurourology and Urodynamics, Brosche et al. 
Seven‑year efficacy and safety outcomes of Bulkamid for SUI.  

2020, Journal of Urology, Itkonen et. Al 
TVT vs PAHG for primary SUI — RCT.  

2020, The International Urogynecology Journal, Dwyer et al.
“Voice your choice”: Women’s choice of surgery for primary SUI.  

2019, Journal of Urology, Itkonen et al.
TS. TVT vs PAHG for primary SUI: randomized clinical trial.  

2015, Central European Journal of Urology, Pai et al. 
Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid®) in stress and mixed urinary incontinence: 3‑year follow‑up.  

2014, Journal of Urology, Sokol et al.   
Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: randomized, prospective, multicenter North American study. 

2013, The Archives of Gynecology Obstetrics, Leone et al.
Outpatient periurethral injections of polyacrylamide hydrogel for female stress urinary incontinence: effectiveness and safety.  

2012, The Journal of Sexual Medicine, Leone et al. 
Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: impact on female sexual function.  

2012, International Urogynecology Journal, Toozs-Hobson et al.
Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and stress‑predominant mixed incontinence. 

2010, International Urogynecology Journal, Lose et al.
An open multicenter study of polyacrylamide hydrogel (Bulkamid®) for female stress and mixed urinary incontinence. 

 

Technical specifications

Bulkamid™ Urethral Bulking System Kit

 

Product details
Needles12 cm, 23-gauge with 1 cm markers
Rotatable Sheath360 degrees, diameter 22 Fr
Syringes1 mL each, with 0.1 mL markers
*Does not include Bulkamid Cystoscope


Bulkamid™ Cystoscope

 

Product details
Direction of view0 degrees
Field of view90 degrees
Technical description
Length113 mm
Diameter2.7 mm
Field of view90 degrees

Ordering information

 

UPNDescription
50050Bulkamid Urethral Bulking System
OM-1000-CISterilization tray
41-0152ACystoscope - 2.7 mm x 113 mm, 0°

Questions?

We are here to help answer any questions you may have about Bulkamid.

Contact us

References

  1. Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40:502–508.
  2. Dwyer et al., “Voice your choice”: A study of women's choice of surgery for primary stress urinary incontinence. International Urogynecology Journal (2020) 31:769–777

Caution: U.S. Federal law restricts this device to sale by or the order of a physician trained in use of surgical mesh for the repair of stress urinary incontinence.

All images are owned by Boston Scientific. All trademarks are the property of their respective owners.